KOD
43.13 USD
+2.30%
Today
+0.92%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 11:00 PM
Tue
4:30 PM ~ 11:00 PM
Wed
4:30 PM ~ 11:00 PM
Thu
4:30 PM ~ 11:00 PM
Fri
4:30 PM ~ 11:00 PM
Sat
Closed
Information
Name
Kodiak Sciences Inc Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
2.62B
Avg Daily Volume
3.04M
52 Week High
45.6 USD
52 Week Low
1.92 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), a bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Top News
Adobe
-1.89%
Coeur
+2.59%
Commercial_Metals
-0.06%
CNX_Resources
+1.01%
Designer.Brands
+2.83%
Freeport_Mcmoran
+2.43%
Generac
+0.23%
Alphabet-Class-A
-0.25%
Hecla.Mining
+0.73%
RobinHood
-1.55%
Jefferies
+1.38%
Kodiak_Sciences
+0.92%
Liberty.Energy
+1.10%
Lovesac
-2.56%
NewmontM
+2.35%
SouthernCopper
+2.32%
ScottsMiracle-Gro
-2.66%
Stryker
+0.14%
UnitedNaturalFoods
-2.56%
BUZZ-U.S. STOCKS ON THE MOVE -Adobe, Salesforce, Stryker
reuters.com
2w ago
Coeur
+2.59%
Commercial_Metals
-0.06%
Designer.Brands
+2.83%
Freeport_Mcmoran
+2.43%
Generac
+0.23%
Alphabet-Class-A
-0.25%
Hecla.Mining
+0.73%
RobinHood
-1.55%
Jefferies
+1.38%
Kodiak_Sciences
+0.92%
Liberty.Energy
+1.10%
Lovesac
-2.56%
NewmontM
+2.35%
SouthernCopper
+2.32%
ScottsMiracle-Gro
-2.66%
UnitedNaturalFoods
-2.56%
BUZZ-U.S. STOCKS ON THE MOVE -Firefly Neuroscience, Liberty Energy, ImmunityBio
reuters.com
2w ago
Wall Street Digests Fading Middle East Peace Prospects as US Equity Futures Decline Pre-Bell
finance.yahoo.com
2w ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
